United States (US) Preventable Vaccines Market (2025-2031) | Share, Analysis, Industry, Outlook, Competitive Landscape, Value, Trends, Segmentation, Growth, Companies, Size & Revenue, Forecast

Market Forecast By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Others), By Indication (Pneumococcal Disease, Influenza, Polio, Hepatitis, Others), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) And Competitive Landscape
Product Code: ETC9974490 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Preventable Vaccines Market Outlook
  • Market Size of United States (US) Preventable Vaccines Market, 2024
  • Forecast of United States (US) Preventable Vaccines Market, 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Revenues & Volume for the Period 2021- 2031
  • United States (US) Preventable Vaccines Market Trend Evolution
  • United States (US) Preventable Vaccines Market Drivers and Challenges
  • United States (US) Preventable Vaccines Price Trends
  • United States (US) Preventable Vaccines Porter's Five Forces
  • United States (US) Preventable Vaccines Industry Life Cycle
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Technology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Inactivated Vaccines for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Live Attenuated Vaccines for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Toxoid Vaccines for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Pneumococcal Disease for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Influenza for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Polio for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Hepatitis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Preventable Vaccines Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • United States (US) Preventable Vaccines Import Export Trade Statistics
  • Market Opportunity Assessment By Technology
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End User
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Preventable Vaccines Top Companies Market Share
  • United States (US) Preventable Vaccines Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Preventable Vaccines Company Profiles
  • United States (US) Preventable Vaccines Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Preventable Vaccines Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Preventable Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Preventable Vaccines Market - Industry Life Cycle

3.4 United States (US) Preventable Vaccines Market - Porter's Five Forces

3.5 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) Preventable Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F

3.9 United States (US) Preventable Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Preventable Vaccines Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Preventable Vaccines Market Trends

6 United States (US) Preventable Vaccines Market, By Types

6.1 United States (US) Preventable Vaccines Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F

6.1.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F

6.1.5 United States (US) Preventable Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F

6.1.6 United States (US) Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Preventable Vaccines Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F

6.2.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F

6.2.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Polio, 2021- 2031F

6.2.5 United States (US) Preventable Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F

6.2.6 United States (US) Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Preventable Vaccines Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Parenteral, 2021- 2031F

6.4 United States (US) Preventable Vaccines Market, By End User

6.4.1 Overview and Analysis

6.4.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 United States (US) Preventable Vaccines Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Preventable Vaccines Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 United States (US) Preventable Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 United States (US) Preventable Vaccines Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 United States (US) Preventable Vaccines Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7 United States (US) Preventable Vaccines Market Import-Export Trade Statistics

7.1 United States (US) Preventable Vaccines Market Export to Major Countries

7.2 United States (US) Preventable Vaccines Market Imports from Major Countries

8 United States (US) Preventable Vaccines Market Key Performance Indicators

9 United States (US) Preventable Vaccines Market - Opportunity Assessment

9.1 United States (US) Preventable Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United States (US) Preventable Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 United States (US) Preventable Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) Preventable Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F

9.5 United States (US) Preventable Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Preventable Vaccines Market - Competitive Landscape

10.1 United States (US) Preventable Vaccines Market Revenue Share, By Companies, 2024

10.2 United States (US) Preventable Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All